Slide background
Slide background

Medicinal VIPR Package

ID 8337 | | Visite: 976 | Documenti Chemicals EntiPermalink:

218 19

Medicinal VIPR Package - Lifetime Performance of Drug Delivery Device

EIGA Doc. 218/19

One of the major developments on how medicinal gases are delivered to patients has been the introduction of cylinders fitted with valves that have an integrated pressure regulator.

These medical gas cylinder packages fitted with a valve with integrated pressure regulators (VIPRs) offer a number of significant benefits to both the healthcare professional and the homecare patient when administering the medicinal gas for clinical treatment.

The medical VIPR packages have now been in service for more than twenty years and they have proven to be both reliable and beneficial to those administering medicinal gas from cylinders. Although the medical VIPR packages are used predominantly in medical oxygen service, they can be used for other gases and gas mixtures, including medical air and nitrous oxide/oxygen analgesic gas mixtures.

Although the intended performance of the medical gas VIPR (when initially put into service) is specified in the valve manufacturer’s technical file, the pharmaceutical legislation also requires the gas manufacturer to ensure that the valve is performing correctly each time the cylinder is filled and supplied for patient use over its complete service life. It is important that the VIPR will control the gas supply accurately, as both over and under administration of the gas can lead to patient harm. By establishing a process of valve performance verification and by trending any report received from the customer, it is possible to provide the appropriate assurances that the medical VIPR will function correctly.

This publication is a guideline that describes the basic requirements for the tests that the VIPR manufacturer should perform and the performance checks carried out by the gas manufacturer. This will assist to ensure that the VIPR performs as intended throughout its service life.

This publication applies to filled medicinal VIPR packages used to administer medicinal gases by healthcare professionals and homecare patients.

Table of Contents
Scope and purpose
2.1 Scope
2.2 Purpose
3.1 Publication terminology
3.2 Technical definitions
Intended performance of medicinal VIPRs
Test requirement for VIPR manufacturers
5.1 General
5.2 Cleaning
5.3 Test conditions for additional tests
5.4 Additional tests to be performed on every medicinal VIPR
Requirements for gas manufacturers
6.1 Initial qualification of a model of VIPR
6.2 Incoming inspection
6.3 VIPR fitting
6.4 First fill
6.5 Post-maintenance fill
Medical VIPR package refilling 
7.1 Pre-fill testing 
7.2 Tests and inspection after filling 
Management of rejected VIPRs at gas manufacturer
Reporting to health authorities 
Other references 
Appendix 1 – Typical Risk Assessment
Appendix 2 - Technical part on medicinal VIPR
Appendix 3 - Flow delivery to the patient
Appendix 4 – Regulatory background

Fonte: EIGA


Tags: Chemicals Abbonati Chemicals

Articoli correlati

Ultimi archiviati Chemicals

Regolamento di esecuzione UE 2020 1771
Nov 27, 2020 20

Regolamento di esecuzione (UE) 2020/1771

Regolamento di esecuzione (UE) 2020/1771 della Commissione del 26 novembre 2020 che approva la massa di reazione di acido peracetico (PAA) e acido perossiottanoico (POOA) come principio attivo esistente ai fini del suo uso nei biocidi dei tipi di prodotto 2, 3 e 4 GU L 398/9 del 27.11.2020 Entrata… Leggi tutto
Regolamento di esecuzione UE 2020 1763
Nov 26, 2020 52

Regolamento di esecuzione (UE) 2020/1763

Regolamento di esecuzione (UE) 2020/1763 della Commissione del 25 novembre 2020 che approva la formaldeide come principio attivo esistente ai fini del suo uso nei biocidi dei tipi di prodotto 2 e 3 GU L 397/17 del 26.11.2020 Entrata in vigore: 16.12.2020 ______ Articolo 1 La formaldeide è approvata… Leggi tutto
Learning lessons from accidents
Nov 19, 2020 58

JRC 2020 | Learning lessons from accidents - Seveso III

JRC 2020 | Learning lessons from accidents - Seveso III JRC-EU, 18.11.2020 Punti chiave e conclusioni per gli ispettori dei principali siti di rischio chimico: una pubblicazione della serie di ispezioni Seveso È indiscusso che imparare dagli incidenti è una parte essenziale e importante del… Leggi tutto
Stainless Steel in in the Dairy Industry
Nov 17, 2020 58

Stainless Steel in the Dairy Industry

Stainless Steel in the Dairy Industry: A Sustainable Solution for Human Diet Stainless Steel a Sustainable Material for: 1. PeopleBefore we can determine whether stainless steel is a sustainable material, we should first define what we mean by sustainability in relation to what is known as the… Leggi tutto
Hazard Classification and Labelling of Petroleum Substances in the EC Area
Nov 12, 2020 67

Hazard Classification and Labelling of Petroleum Substances in the EC Area

Hazard Classification and Labelling of Petroleum Substances in the European Economic Area This report contains an assessment of the hazardous properties of petroleum substances against the criteria of the CLP Regulation (EC 1272/2008) up to and including the 13th ATP (EU, 2018b) and Corrigendum to… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Feb 28, 2020 38211

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto
Regolamento  CE  852 2004
Mar 06, 2019 30677

Regolamento (CE) N. 852/2004

Regolamento (CE) N. 852/2004 Regolamento (CE) N. 852/2004 del Parlamento europeo e del Consiglio del 29 aprile 2004 sull'igiene dei prodotti alimentari GU L 139/1 del 30.4.2004 Testo consolidato 2009Modificato da: Regolamento (CE) n. 1019/2008 della Commissione del 17 ottobre 2008 (GU L 277 7… Leggi tutto